Home › Degenerative Nerve Diseases › Massachusetts
Degenerative Nerve Diseases clinical trials in Massachusetts
6 studies for Degenerative Nerve Diseases are looking for participants at sites in Massachusetts.
Cities in Massachusetts
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
- Massachusetts General Hospital /ID# 270960, Boston
RecruitingPhase 1/2
6 Months · All sexes · Updated Sep 24, 2026 · NCT05757141A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Massachusetts General Hospital - Charlestown, Charlestown
- K2 Medical Research - Foxborough, Foxborough
- Neurology Center of New England, Foxborough
- and 1 more
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Massachusetts General Hospital (MGH), Charlestown
RecruitingPhase 1
Ages 50 to 85 · All sexes · Updated Aug 24, 2026 · NCT06297590PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Boston University, Boston
- Massachusetts General Hospital, Boston
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Jul 27, 2026 · NCT04477785Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
- Boston Children's Hospital, Boston
RecruitingObservational study
1 Month – 30 Years · All sexes · Updated Mar 18, 2026 · NCT05354622Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- McLean Hospital, Belmont
RecruitingObservational study
Ages 18 to 89 · All sexes · Updated Nov 6, 2025 · NCT05245903From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.